Zobrazeno 1 - 10
of 36
pro vyhledávání: '"M C Malet-Martino"'
Publikováno v:
Journal of Chemical Technology and Biotechnology. Chemical Technology. 35:73-82
Publikováno v:
International Journal of Cosmetic Science. 20:117-125
The reliability of in vitro proton nuclear magnetic resonance (NMR) spectroscopy to specifically measure the water content of rehydrated human stratum corneum samples was assessed by comparison with the previously validated thermal desorption-mass sp
Publikováno v:
British Journal of Cancer
We report the first demonstration of the biotransformation of the anti-cancer drug 5-fluorouracil (FU) into two new metabolites, alpha-fluoro-beta-hydroxypropionic acid (FHPA) and fluoroacetate (FAC), in the isolated perfused rat liver (IPRL) and in
Autor:
Robert Martino, Ion Neda, Ulf Niemeyer, M. C. Malet-Martino, Reinhard Schmutzler, Bernhard Kutscher, Véronique Gilard, Jürgen Engel, Peter G. Jones, Axel Fischer
Publikováno v:
Phosphorus, Sulfur, and Silicon and the Related Elements. 109:473-476
The degradation of cyclophosphamide in neutral or slightly acidic aqueous solution starts with an intramolecular alkylation leading to an intermediary bicyclic compound which hydrolyses immediately and exclusively to a nine-membered heterocycle. Subs
Publikováno v:
Nucleosides and Nucleotides. 12:331-350
The protected (4a-9a) and deprotected (4b-6b, 8b) glucuronides of 5-fluorocytosine and 5-fluorouracil were synthesized and characterized by mass spectrometry and 19F, 1H and 13C NMR. The substitution position of the sugar moiety on the pyrimidine rin
Autor:
M C Malet-Martino, Robert Martino
Publikováno v:
Clinical Pharmacokinetics. 20:337-349
Publikováno v:
Drug metabolism and disposition: the biological fate of chemicals. 23(8)
The structure of a glucuronide metabolite of flucytosine (FC; 5-fluorocytosine), found in the urine of all patients treated with this antifungal drug, was determined. This compound is the O2-beta-glucuronide of FC. Its structure was established after
Publikováno v:
Oncology Reports
Oncology Reports, Spandidos Publications, 1994, 1 (1), pp.173-4. ⟨10.3892/or.1.1.173⟩
ResearcherID
Oncology Reports, 1994, 1 (1), pp.173-4. ⟨10.3892/or.1.1.173⟩
Oncology Reports, Spandidos Publications, 1994, 1 (1), pp.173-4. ⟨10.3892/or.1.1.173⟩
ResearcherID
Oncology Reports, 1994, 1 (1), pp.173-4. ⟨10.3892/or.1.1.173⟩
International audience; The cardiotoxicity of 5-fluorouracil (FU) was attributed to degradation compounds present in the injected vials, fluoroacetaldehyde (Facet) and fluoromalonaldehydic acid (FMald). FU-NaOH vials were much less cardiotoxic than F
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e23ef887408d3ab3dc6f890e38523444
https://hal.univ-angers.fr/hal-02374762
https://hal.univ-angers.fr/hal-02374762
Publikováno v:
Cancer chemotherapy and pharmacology. 31(5)
Phosphorus-31 nuclear magnetic resonance spectroscopy was used to analyze urine samples obtained from patients treated with ifosfamide (IF). This technique allows the individual assay of all phosphorated metabolites of IF in a single analysis without
Publikováno v:
British Journal of Cancer
British Journal of Cancer, Cancer Research UK, 1992, 66 (1), pp.119-127. ⟨10.1038/bjc.1992.227⟩
British Journal of Cancer, 1992, 66 (1), pp.119-127. ⟨10.1038/bjc.1992.227⟩
British Journal of Cancer, Cancer Research UK, 1992, 66 (1), pp.119-127. ⟨10.1038/bjc.1992.227⟩
British Journal of Cancer, 1992, 66 (1), pp.119-127. ⟨10.1038/bjc.1992.227⟩
International audience; The cardiotoxicity of 5-fluorouracil (FU) was attributed to impurities present in the injected vials. One of these impurities was identified as fluoroacetaldehyde which is metabolised by isolated perfused rabbit hearts into fl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c9222b40247b462e8a46057f90230b3f
https://hal.univ-angers.fr/hal-02374741
https://hal.univ-angers.fr/hal-02374741